The Effect of Mankai on Glycemic Control Among Patients With T2D

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 104 participants.

Also called NCT06416475

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Ben-Gurion University of the Negev (from the registry)
Registry
  • NCT NCT06416475
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Israel (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06416475. Randomized; no masking; primary purpose treatment. Start 2024-04-30 (actual); primary completion 2024-08-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Mankai on Glycemic Control Among Patients With T2D
Condition
Diabetes Mellitus, Type 2
Intervention (Dietary supplement)
Mankai supplementation
Intervention (Other)
Water consumption
Lead sponsor
Ben-Gurion University of the Negev (class: other)
Collaborator
Soroka University Medical Center (class: other)

Record details

Record id
cardio:ct-nct06416475
Content hash
78c83495c6f6bac223c0b4d78f40e5773a74b4c3bdf8eaaf1834ec64dc61eeeb